Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Matson Inc (MATX) vs Morgan Stanley (MS) Price & Performance

Matson IncTrade
Morgan StanleyTrade

Price performance (Past 24H)

Key statistics

Matson Inc vs Morgan Stanley — how do they compare? Matson Inc trades at $226.75 (market cap $6.81B), while Morgan Stanley trades at $189.11 (market cap $294.39B). The key difference: Morgan Stanley is far larger — about 43.2× Matson Inc's market cap, and Morgan Stanley pays the higher dividend (2.45%). Which is the better fit depends on your goals — on Pluang, investors hold Matson Inc for 23 Days and Morgan Stanley for 93 Days on average.

MATXMS
Market Cap
$6.81B$294.39B
Volume
255,0805,836,423
Sector
IndustrialsFinancials
52-Week High
$238.60$228.42
52-Week Low
$88.05$151.86
Typical Hold Time
23 Days93 Days
Enterprise Value
$7.41B$660.04B
Dividend Yield
0.67%2.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Matson Inc

Matson (MATX) trades at $222.92, down 0.83% on the day, with technical indicators showing a neutral to bearish short-term bias. The company demonstrates strong fundamental performance with consistent earnings beats, including Q2 2026 EPS of $4.27 versus $3.79 expected, and maintains healthy profitability with a 13.41% net income margin. Recent news highlights institutional buying interest and positive analyst sentiment toward the transportation services sector.

MATX presents a compelling investment case with solid earnings growth, attractive valuation metrics (P/E of 15.37), and strong analyst support (66.7% buy ratings). Key risks include freight market volatility and competitive pressures, but the company's raised full-year outlook and dividend payments provide stability. The stock offers potential upside with Wall Street analysts projecting 27.3% price target upside.

Morgan Stanley

Morgan Stanley (MS) trades at $189.71, down 0.66% with bearish technical signals despite strong fundamentals. The company has delivered three consecutive earnings beats with Q2 2026 EPS of $3.46 beating expectations by $0.57. Revenue growth accelerated to $66.0 billion in 2025 with net income margin expanding to 27.59%. Analyst consensus remains bullish with 55.77% buy ratings and a $229.25 price target representing 21% upside potential.

The investment case balances strong profitability and growth opportunities in wealth management and AI financing against concerning cash flow trends and technical weakness. While valuation appears reasonable at 15.14 P/E, investors face risks from volatile operating cash flows and rising debt levels. The stock offers attractive upside to analyst targets but requires monitoring of capital markets recovery timing.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MATX

No sentiment data available yet.

MS
100% Buy0% Sell
Avg holding period · 93 Days

Top news

Latest headlines on both assets

About Matson Inc

Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.

Read more on MATX →

About Morgan Stanley

Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.

Read more on MS →